Laura Vilar-Ribó Joins the Lab as a Postdoctoral Researcher!
We are delighted to announce Dr. Laura Vilar-Ribó officially returned to the Sanchez-Roige lab as a postdoctoral researcher in March 2024!
Dr. Vilar-Ribó’s work focuses on unraveling the underlying genetic mechanisms that contribute to the development of psychiatric disorders and complex traits, particularly Substance Use Disorders (SUD), Attention-deficit Hyperactivity Disorders (ADHD) and impulsivity.
During her research career, Dr. Vilar-Ribó was exposed to complex quantitative genomic techniques, including Genome-Wide Association Studies, Polygenic Scores, Phenome-Wide Association Studies, fine-mapping, LD-Score regression, genomic SEM, Mendelian Randomization, MiXer, among others. Additionally, she worked with large-scale datasets such as the UK Biobank, 23andMe, BioVU and Allofus.
Dr. Vilar-Ribó is a highly collaborative researcher; she is an active member of multiple international consortiums, including a Psychiatric Genomics Consortium SUD workgroup (PGC-SUD) and the PsycheMERGE consortium. Through collective efforts and interdisciplinary approaches, she shows her commitment to advancing our understanding of psychiatric genetics and translating these findings into effective interventions and treatments for individuals affected by these conditions.
Welcome (back) to the team, Laura!
New article accepted at the Nature Human Behavior!
The article entitled "Multi-ancestry meta-analysis of tabacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes" has been accepted for publication at Nature Human Behavior! Mariela Jenning, Benjamin Pham, Sevim Bianchi, John Meredith, Laura Vilar-Ribó, Michael Ehinmowo, Shreya Pakala, and Brittany Leger are co-authors and Sandra Sanchez-Roige is the lead investigator.
